SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001288123-14-000016
Filing Date
2014-02-28
Accepted
2014-02-28 16:16:46
Documents
1
Period of Report
2014-02-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3185
  Complete submission text file 0001288123-14-000016.txt   4627
Mailing Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010
Business Address 162 FIFTH AVENUE SUITE 900 NEW YORK NY 10010 212-994-8200
AGENUS INC (Issuer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address AGENUS INC. 3 FORBES ROAD LEXINGTON MA 02421
Business Address
Wentworth Kerry (Reporting) CIK: 0001369453 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29089 | Film No.: 14655583